Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Reuters NewMedia - August 10, 2009
Tan Ee Lyn
"The Global Fund is funding about 25,000 to 30,000 patients but the estimated total number of cases is 500,000," Michel Kazatchkine, executive director of the Global Fund's effort to fight HIV/AIDS, TB and malaria, told an HIV/AIDS conference.
"So we are very far off. It is a dangerous epidemic that is spreading," he told the conference in Bali. "There is an underdiagnosis of MDR-TB."
The Asia-Pacific region has the highest number of multi-drug resistant TB (MDR-TB), but only one percent of the cases are being treated, he added.
Most cases of TB can be cured with a drug regimen of 6 to 8 months. Multi-drug resistant TB emerges when there is improper use of antibiotics in fighting regular TB, such as failure to complete the whole course of treatment.
People with HIV/AIDS are especially susceptible to falling ill with TB because their immune systems are compromised. An estimated one-third of people living with HIV are co-infected with TB, and TB continues to be the leading cause of death among people living with HIV.
The emergence of multi-drug resistant TB and extensively drug-resistant TB in recent years poses a significant public health threat, especially for countries with high HIV prevalence. Multi-drug resistant TB is resistant to two of the most powerful TB drugs, isoniazid and rifampicin.
Kazatchkine said treatment for someone with multi-drug resistant TB costs US$7,000 a year, about 100 times the cost of treating regular TB.
"The best way to prevent resistant TB is to get people to take the whole course of standard TB drugs," he said. He stressed, however, there was still an urgency to allocate more money to treat people with multi-drug resistant TB.
"If we can do it for H1N1, we can do it for TB. These epidemics have been at (pandemic) level 6 plus plus plus plus for years," he said.
090810
RE090808
Copyright © 2009 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .